Propane

Propane

SCHEMBL4417404

CCC.Fc1ccc(-c2ccnc(-c3ccc(F)cc3)c2)cc1.N

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 2/20 0.50
TGFBR1 P36897 2/20 0.46
SREBF2 Q12772 1/20 0.46
MAPK10 P53779 1/20 0.42
MAP4K4 O95819 2/20 0.42
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
WNT3A P56704 2/20 0.40
ATM Q13315 1/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
MAPK14 Q16539 1/20 0.39
PHF8 Q9UPP1 1/20 0.39
CYP3A4 P08684 1/20 0.38
TOP1 P11387 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28802099 0.85 KDM4E (0.50) MAPKAPK2TGFBR1MAPK10MAP4K4MAPK14
SCHEMBL6408354 0.85 MAPK10 (0.55) MAPKAPK2TGFBR1MAPK10MAP4K4MEN1
SCHEMBL27562868 0.84 TGFBR1 (0.54) MAPKAPK2TGFBR1MAPK10MAP4K4TOP1
SCHEMBL23278789 0.82 TGFBR1 (0.52) MAPKAPK2TGFBR1MAPK10TOP1MAPT
SCHEMBL13534468 0.79 NOS3 (0.47) MAPKAPK2TGFBR1SREBF2MEN1KMT2A
SCHEMBL14015421 0.76 SREBF2 (0.50) SREBF2MAPK10MAP4K4RAB9ANPC1
SCHEMBL28605297 0.76 MEN1 (0.47) MAPKAPK2TGFBR1MAPK10MAP4K4MEN1
SCHEMBL12885515 0.76 KMO (0.48) MAPKAPK2TGFBR1MAPK10MAP4K4MEN1
SCHEMBL842265 0.76 CCR1 (0.61) TGFBR1MEN1KMT2ARAB9ANPC1
SCHEMBL15506226 0.75 TGFBR1 (0.51) TGFBR1SREBF2MAP4K4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264446-A9 Condensed Pyridines as Kinase Inhibitors PALAU PHARMA, S.A. (ES) 2009-10-22 US disclosed
US-20080318977-A1 Condensed Pyridines as Kinase Inhibitors PALAU PHARMA, S.A. (ES) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264446-A9 Condensed Pyridines as Kinase Inhibitors MAPK1, MAP4K2, MAP3K1 MAPKAPK2 21/4885TGFBR1 2486/4885SREBF2 3358/4885
US-20080318977-A1 Condensed Pyridines as Kinase Inhibitors MAPK1, MAP4K2, MAP3K1 MAPKAPK2 21/4885TGFBR1 2486/4885SREBF2 3358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.